pentobarbital will decrease the extent or effect of buprenorphine, lengthy-acting injection by impacting hepatic/intestinal enzyme CYP3A4 metabolism. Modify Therapy/Observe Intently. Clients who transfer to buprenorphine extensive-performing injection from transmucosal buprenorphine coadministered with CYP3A4 inducers should be monitored to be sure